INTRAUTERINE GROWTH RESTRICTION - PowerPoint PPT Presentation

1 / 19
About This Presentation
Title:

INTRAUTERINE GROWTH RESTRICTION

Description:

– PowerPoint PPT presentation

Number of Views:1993
Avg rating:3.0/5.0
Slides: 20
Provided by: obg8
Category:

less

Transcript and Presenter's Notes

Title: INTRAUTERINE GROWTH RESTRICTION


1
INTRAUTERINE GROWTH RESTRICTION
  • By
  • DR NOSHABA RAFIQ
  • M.B.B.S M.C.P.S F.C.P.S.

2
DEFINITION OF IUGR
  • Fetus whose estimated weight is
  • less than 10th percentile for its gestational
    age.
  • Abdominal circumference is less than 2.5th
    percentile.
  • Incidence 10 percent of all pregnancies.

3
Fetal weight percentiles throughout gestation
4
Risk of IUGR Babies
  • Still birth 15 fold increase risk
  • Intra-partum hypoxia
  • Neonatal risk
  • Sepsis
  • Hypoglycemia
  • RDS
  • Hypothermia
  • Meconium Aspiration
  • Haematological disorders
  • Seizers in first 24 hours
  • Malformations

5
contd
  • 4. Impaired Neurodevelopment
  • Long term neuromotor dysfunction
  • Poor school performance
  • Deficits in academic achievements
  • 5. Complications in Adult Life
  • Obesity
  • Diabetes Mellitis
  • Hypertension
  • Cardio-vascular disease

6
Classification of IUGR
  • Symmetrical growth restriction fetus whose
    entire body is proportionally small.
  • Incidence 20
  • Asymmetrical growth restriction Decrease in
    subcutaneous fat and abdominal circumference with
    relative sparing of head circumference and femur
    length.
  • Incidence 80

7
ETIOLOGY
  • Maternal Causes of IUGR
  • Chronic Illnesses (e.g. cystic fibrosis, CHD,
    renal failure, haemoglobinopathies, APS)
  • Nutrition (e.g. anorexia nervosa and bulimia)
  • Smoking
  • Alcohol
  • Drug Abuse (e.g. Cocaine, amphetamines, betal
    chewing)

8
contd
  • Infections (e.g. vaginal bacteria, specially M.
    hominis, U. urealyticum, T. vaginalis and
    bacteroides group).
  • Endocrine disorders (e.g. diabetic nephropathy,
    hyperthyroidism, addisons disease).

9
Placental Causes of IUGR
  • Uteroplacental insufficiency
  • Unexplained
  • Preeclampsia
  • Elevated maternal AFP
  • 2. Fetoplacental insufficiency
  • Single Umbilical Artery
  • Velamentous insertion of cord
  • Placental Haemangioma
  • 3. Abnormal Placentation
  • Abruptioplacentae
  • Placenta Previa
  • Placenta Accretia

10
Fetal Causes of IUGR
  • Normal Small Fetus (Constitutionally small fetus)
  • 2. Infection
  • CMV
  • Toxoplasmosis
  • Rubella
  • Herpes
  • Malaria
  • Syphilis

11
contd
  • 3. Fetal Abnormality
  • Chromosomal (Trisomy, 13,18 and 21, deletions or
    tripliody)
  • Structural (Gastroschisis, e.g. anencepholy)
  • 4. Multiple Gestation

12
DIAGNOSIS OF IUGR
  • 1. History
  • Previous infant with growth restriction
  • Decreased fetal movements
  • Medical disorders
  • Drugs
  • Poor nutrition
  • Adverse factors, e.g. bleeding
  • 2. Clinical Examination
  • Poor maternal weight gain
  • Fundal height lag
  • Reduced amount of liquour
  • Clinical assessment of small fetus

13
contd
  • HC/AC ratio or FL/AC ratio
  • Estimated Fetal weight
  • 4. Growth Velocity
  • Serial measurements of AC or EFT
  • 5. Invasive Investigation
  • Karyotyping
  • Screening for congenital infections

14
Doppler Ultrasound
  • Umblical Artery
  • S/D ratio
  • Resistance index
  • Pulsatility index
  • Middle Cerebral Artery
  • Venous Doppler
  • Reversal of blood flow in IVC, DV and UV at the
    end of diastole

15
MANAGEMENT
  • Accurate dating is mandatory
  • Symmetric or Asymmetric IUGR
  • Assymmetric rule out chromosomal abnormalities
    and congenital infections.
  • 3. General Management
  • Treat maternal disease
  • Stop substance abuse
  • Good nutrition
  • Bed Rest
  • Maternal hyperoxygenation

16
ANTENATAL SERVEILLANCE
  • Growth scans every 3 weeks
  • Daily fetal movement profile
  • NST twice weekly
  • BPP weekly if NST is abnormal
  • Umblical artery Doppler study every 2 to 3 weeks.
  • Oxytocin challenge test if NST is abnormal or BPP
    is lt8

17
DELIVERY CONSIDERATIONS
  • Antenatal steroids To promote fetal lung
    maturity if gestational age less than 34 weeks.
  • Delivery gt 32 weeks If antenatal test results
    are abnormal.
  • Antenatal test results reassuring continue fetal
    surveillance and delivery at term, if fetal
    growth is noted.
  • If no fetal growth or severe oligohydramnios
    assess fetal lung maturity. Deliver if lungs are
    mature otherwise, reassess after 1 week.
  • Abnormal antenatal test results at less than 32
    weeks of gestation, each case must be considered
    individually.

18
LABOR AND DELIVERY
  • Continuous fetal monitoring during labor.
  • Delivery in hospital, capable of providing
    intensive neonatal care.
  • Amnioinfusion non-reassuring fetal response, low
    amniotic fluid index and meconium stained liquor.
  • Caesarean Section Detoriating fetal status.

19
THANK YOU
Write a Comment
User Comments (0)
About PowerShow.com